Influencer Brianna LaPaglia, known as “Chickenfry,” has clarified recent comments she made regarding the use of Ozempic, a medication increasingly used for weight loss. LaPaglia initially sparked controversy with a TikTok video suggesting those using the drug were “all gonna die,” prompting widespread discussion and criticism. She has since explained that her remarks were specifically directed toward individuals who are already at a low weight and, in her view, do not medically require the medication.
The initial video, posted on March 10, touched on the growing prevalence of Ozempic use among her social circle. LaPaglia’s follow-up, shared on March 12, aimed to refine her message, emphasizing her concern for those she believes are misusing the drug. This conversation unfolds against a backdrop of increasing Ozempic prescriptions, even as the medication was originally approved to treat type 2 diabetes. According to a Gallup National Health and Well-Being Index survey, GLP-1 drug use—which includes Ozempic—more than doubled between 2024 and 2025, rising from 5.8% to 12.4% of respondents.
Clarifying the “All Gonna Die” Statement
In her clarifying TikTok, LaPaglia stated she was referring to “skinny bitches” – specifically those who are sizes 2 or 0 – and using Ozempic unnecessarily. “When I say you’re gonna die, I signify, it’s because you are literally starving yourself,” she explained. “If anything, you necessitate to gain weight.” She distinguished this group from individuals for whom Ozempic has been a beneficial medical intervention, citing the positive impact the drug has had on her aunt and cousin.
LaPaglia’s comments come as concerns grow regarding the off-label use of medications like Ozempic. While effective for weight loss by promoting feelings of fullness and reducing food intake, as previously reported by USA Today, the drugs are not without potential side effects. These can include nausea, vomiting, diarrhea, constipation, heartburn, fatigue, dehydration, and muscle loss. Prolonged use at higher doses, particularly when combined with a low-calorie diet, may also lead to hair thinning.
Backlash and Support for LaPaglia’s Position
LaPaglia’s initial statement drew a mixed reaction online. Some, like plastic surgeon Dr. Terry Dubrow, a vocal advocate for Ozempic, questioned her qualifications to comment, stating on social media, “Someone should revoke her medical license. Oh wait…” Others expressed skepticism about LaPaglia’s motives, while some users agreed with her assessment, arguing that the drug is being misused by individuals who do not need it. One user commented, “I mean she’s technically not wrong.”
The debate highlights a broader conversation about body image, eating disorders, and the pressures surrounding weight loss. Bethenny Frankel, founder of Skinnygirl, has also recently voiced concerns about the use of Ozempic for cosmetic purposes, warning about potential risks for individuals with body dysmorphia or pre-existing eating disorders.
LaPaglia reiterated her stance, stating that those who genuinely need Ozempic should continue to use it, but cautioned against its use by those already at a healthy weight. “You bitches that are size 2 and size 0, it’s f***ed up,” she said. “And yeah, you’re all gonna die, not because of the Ozempic, but because you’re gonna be malnourished and you’re gonna faint and you’re gonna hit your head. Do I need to repeat myself?”
As the use of GLP-1 medications continues to rise, the discussion surrounding responsible usage and potential health consequences is likely to intensify. Further research and public health guidance will be crucial in navigating the complex issues surrounding these drugs and their impact on individuals and society.
Disclaimer: The information provided in this article is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the increasing use of Ozempic and similar medications? Share your perspective in the comments below.